Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APSCTC for Postsurgical Pain Due to Third Molar Extraction
NCT04647435Phase 3Completed
- Sponsor
- Apsen Farmacêutica
- Start
- May 2023
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of APSCTC in Persistent postsurgical pain (PPSP), sponsored by Apsen Farmacêutica. Started May 2023; status: completed.
02
Drugs
APSCTC
03
Conditions
Persistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on NCT04647435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04647435.